蔚蓝生物(603739.SH)获得新兽药注册证书

Core Viewpoint - Company Blue Biological (603739.SH) has received approval from the Ministry of Agriculture and Rural Affairs for its new veterinary drug "Mirtazapine Ointment," classified as a Category V new veterinary drug, addressing significant clinical signs in cats such as decreased appetite and weight loss [1] Group 1 - The Ministry of Agriculture and Rural Affairs has issued a new veterinary drug registration certificate for "Mirtazapine Ointment," developed by the company and its subsidiaries [1] - The product aims to meet clinical needs in the pet market, particularly for cats, by addressing potential health issues like malnutrition and organ dysfunction due to decreased appetite [1] - The ointment is characterized by controllable quality, safety, effectiveness, ease of administration, and high compliance [1] Group 2 - Currently, the company has not been able to find any similar products in circulation or their market share through public channels [1]